About Chris Garabedian
Form D filings for Tellus Therapeutics from 2021 to 2023 list Chris Garabedian as director.
Chris Garabedian first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Chris Garabedian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Chris Garabedian works with at each company, as listed on that company's latest Form D.
Tellus Therapeutics, Inc. · Form D, Feb 21, 2023
JK
Jason Kralic
President and Chief Executive Officer, director
EB
Eric Benner
Executive officer and director
FC
Fred Callori
Director